thromboxanes has been researched along with Electron Transport Chain Deficiencies, Mitochondrial in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Li, X; Liu, S; Song, S; Su, Z; Wang, C; Wen, R; Xiao, G; Yang, Q | 1 |
1 other study(ies) available for thromboxanes and Electron Transport Chain Deficiencies, Mitochondrial
| Article | Year |
|---|---|
Increased thromboxane/prostaglandin receptors contribute to high glucose-induced podocyte injury and mitochondrial fission through ROCK1-Drp1 signaling.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dynamins; Glucose; Humans; Mice; Mitochondrial Diseases; Mitochondrial Dynamics; Podocytes; Prostaglandins; Receptors, Prostaglandin; Receptors, Thromboxane; rho-Associated Kinases; Streptozocin; Thromboxanes | 2022 |